MEDTRONIC IRELAND VALIANT CAPTIVIA - FF; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR
|
Back to Search Results |
|
Model Number VAMF3636C200TE |
Device Problem
Activation, Positioning or Separation Problem (2906)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 03/26/2024 |
Event Type
malfunction
|
Event Description
|
A valiant captivia stent graft was intended to be implanted in the patient for the endovascular treatment of a 40.9mm thoracic aortic aneurysm.It was reported during the index procedure, when the physician delivered the delivery system into the target anchoring position and started to deploy the stent, the handle of the stent could not rotate.The physician removed the delivery system from the body and replaced it with another size stent.Per the physician the cause was related to the device.No additional clinical sequelae were reported, and the patient is fine.
|
|
Manufacturer Narrative
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Manufacturer Narrative
|
Product analysis conclusions: one (1) image of the valiant captivia device was received.The external slider is partially open, and the graft cover tip appears to be deformed.Snaking is visible along the graft cover indicating difficulties during deployment.The reported deployment/expansion difficulties were confirmed through image review.Conclusion: the reported deployment difficulty could not be confirmed from the two still angiograms provided, therefore, the cause of the event could not be determined.Pre-implant ct¿s were not available for review and a thorough assessment of the patient¿s pre-implant anatomy could not be performed.Procedural angiogram videos showing the deployment attempt was not provided for assessment of the deployment issue.From the limited images available, there was no obvious anatomical findings (i.E.Excessive tortuosity) that could have contributed to the reported event.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Search Alerts/Recalls
|
|
|